171 related articles for article (PubMed ID: 23381914)
1. Adaptive resistance: a tumor strategy to evade immune attack.
Yao S; Chen L
Eur J Immunol; 2013 Mar; 43(3):576-9. PubMed ID: 23381914
[TBL] [Abstract][Full Text] [Related]
2. Myeloid leukemia cells with a B7-2(+) subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands.
Dolen Y; Esendagli G
Eur J Immunol; 2013 Mar; 43(3):747-57. PubMed ID: 23175469
[TBL] [Abstract][Full Text] [Related]
3. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
Dunussi-Joannopoulos K; Dranoff G; Weinstein HJ; Ferrara JL; Bierer BE; Croop JM
Blood; 1998 Jan; 91(1):222-30. PubMed ID: 9414288
[TBL] [Abstract][Full Text] [Related]
4. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.
Karasar P; Esendagli G
Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer.
Krempski J; Karyampudi L; Behrens MD; Erskine CL; Hartmann L; Dong H; Goode EL; Kalli KR; Knutson KL
J Immunol; 2011 Jun; 186(12):6905-13. PubMed ID: 21551365
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
7. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
8. Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1.
Hirst WJ; Buggins A; Darling D; Gäken J; Farzaneh F; Mufti GJ
Gene Ther; 1997 Jul; 4(7):691-9. PubMed ID: 9282170
[TBL] [Abstract][Full Text] [Related]
9. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.
Berthon C; Driss V; Liu J; Kuranda K; Leleu X; Jouy N; Hetuin D; Quesnel B
Cancer Immunol Immunother; 2010 Dec; 59(12):1839-49. PubMed ID: 20814675
[TBL] [Abstract][Full Text] [Related]
10. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
[TBL] [Abstract][Full Text] [Related]
11. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function.
Tamura H; Dong H; Zhu G; Sica GL; Flies DB; Tamada K; Chen L
Blood; 2001 Mar; 97(6):1809-16. PubMed ID: 11238124
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy.
Flies DB; Sandler BJ; Sznol M; Chen L
Yale J Biol Med; 2011 Dec; 84(4):409-21. PubMed ID: 22180678
[TBL] [Abstract][Full Text] [Related]
13. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
Tamura H; Dan K; Tamada K; Nakamura K; Shioi Y; Hyodo H; Wang SD; Dong H; Chen L; Ogata K
Clin Cancer Res; 2005 Aug; 11(16):5708-17. PubMed ID: 16115907
[TBL] [Abstract][Full Text] [Related]
14. Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia.
LaBelle JL; Hanke CA; Blazar BR; Truitt RL
Blood; 2002 Mar; 99(6):2146-53. PubMed ID: 11877291
[TBL] [Abstract][Full Text] [Related]
15. Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells.
Hams E; McCarron MJ; Amu S; Yagita H; Azuma M; Chen L; Fallon PG
J Immunol; 2011 May; 186(10):5648-55. PubMed ID: 21490158
[TBL] [Abstract][Full Text] [Related]
16. Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition.
Greiner J; Götz M; Hofmann S; Schrezenmeier H; Wiesneth M; Bullinger L; Döhner H; Schneider V
Cancer Immunol Immunother; 2020 Apr; 69(4):629-640. PubMed ID: 32020256
[TBL] [Abstract][Full Text] [Related]
17. The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses.
Runyon K; Lee K; Zuberek K; Collins M; Leonard JP; Dunussi-Joannopoulos K
Blood; 2001 Apr; 97(8):2420-6. PubMed ID: 11290606
[TBL] [Abstract][Full Text] [Related]
18. The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression.
Antohe I; Tanasa MP; Dăscălescu A; Dănăilă C; Titieanu A; Zlei M; Ivanov I; Sireteanu A; Cianga P
Immunobiology; 2021 Jan; 226(1):152049. PubMed ID: 33352400
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?
Thompson CB
Cell; 1995 Jun; 81(7):979-82. PubMed ID: 7541314
[No Abstract] [Full Text] [Related]
20. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]